Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 34301-34350 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT06099457
SIBTime Phase II: Web Application for Typically Developing Siblings
NARecruiting
160 participants
Started: Oct 27, 2023 · Completed: Jan 31, 2026
1 condition2 sponsors1 location
NCT06122558
Efficacy of Probiotic Against Functional Constipation
PHASE2Recruiting
104 participants
Started: Oct 27, 2023 · Completed: Oct 26, 2025
1 condition2 sponsors2 locations
NCT05933083
MCNAIR Study: coMparative effeCtiveness of iN-person and teleheAlth cardIac Rehabilitation
NARecruiting
516 participants
Started: Oct 27, 2023 · Completed: Oct 15, 2027
6 conditions6 sponsors5 locations
NCT05786131
Complete Revascularization Versus Culprit Lesion Only PCI in NSTEMI
NARecruiting
3,390 participants
Started: Oct 27, 2023 · Completed: Jul 31, 2027
2 conditions5 sponsors58 locations
NCT06078540
A Mobile Health (mHealth) Strategy for Improving Blood Pressure Control Among Adult Hypertensive African Americans
NARecruiting
30 participants
Started: Oct 27, 2023 · Completed: Oct 31, 2026
2 conditions1 sponsor1 location
NCT05658497
Pregnancy Exposure Registry for Vumerity (Diroximel Fumarate)
N/ARecruiting
908 participants
Started: Oct 27, 2023 · Completed: Jul 6, 2032
1 condition1 sponsor7 locations
NCT06109064
Safety and Efficacy of Unrelated Umbilical Cord Blood Microtransplantation in Patients With Higher-risk MDS
PHASE2Recruiting
14 participants
Started: Oct 27, 2023 · Completed: Feb 1, 2026
1 condition1 sponsor1 location
NCT06170411
Post-marketing Clinical Trial of Elexir(Trigeminal Nerve Electrical Stimulator) for the Acute Treatment of Migraine
NARecruiting
100 participants
Started: Oct 27, 2023 · Completed: Aug 1, 2024
1 condition1 sponsor2 locations
NCT06938464
Preventive Effect of Probiotics in GDM
NARecruiting
334 participants
Started: Oct 27, 2023 · Completed: Nov 1, 2026
1 condition2 sponsors1 location
NCT06008288
A Phase II Study Evaluating JAB-21822 Monotherapy in Adult Patients With Pancreatic Cancer and Other Solid Tumors Harboring the KRAS p.G12C Mutation.
PHASE2Recruiting
88 participants
Started: Oct 27, 2023 · Completed: Dec 31, 2027
3 conditions1 sponsor31 locations
NCT06119958
Drug-drug Interactions Between DWC202313 and DWC202314 in Healthy Subjects
PHASE1Recruiting
32 participants
Started: Oct 27, 2023 · Completed: Dec 31, 2023
1 condition1 sponsor1 location
NCT06057350
Surgery Versus Endoscopic Resection for Incompletely Removed Early Colon CAnceR
NARecruiting
304 participants
Started: Oct 27, 2023 · Completed: Sep 30, 2033
2 conditions13 sponsors3 locations
NCT05914064
Gravitas Feeding Tube System Placement Validation in Neonates
NARecruiting
110 participants
Started: Oct 27, 2023 · Completed: Dec 31, 2026
1 condition1 sponsor3 locations
NCT06492980
A Triple-branched Stent Graft for Aute Debakey Type I Dissection Surgery
NARecruiting
150 participants
Started: Oct 27, 2023 · Completed: Oct 10, 2025
1 condition1 sponsor1 location
NCT05918302
Efficacy and Safety of Radiotherapy Compared to Everolimus in Somatostatin Receptor Positive Neuroendocrine Tumors of the Lung and Thymus.
PHASE3Recruiting
120 participants
Started: Oct 27, 2023 · Completed: Jul 31, 2028
3 conditions3 sponsors23 locations
NCT06319235
Clinical Trial to Demonstrate the Safety and Efficacy of DUOFAG®
PHASE1/PHASE2Recruiting
52 participants
Started: Oct 27, 2023 · Completed: Dec 31, 2025
5 conditions1 sponsor1 location
NCT06267131
Transcutaneous Pulse Oximetry Brain Monitoring Study (US)
NARecruiting
15 participants
Started: Oct 27, 2023 · Completed: Nov 30, 2024
1 condition1 sponsor1 location
NCT06254911
Pre-operative Atezolizumab in Patients With Resectable, Human Papillomavirus Related Oropharyngeal Carcinoma
PHASE2Recruiting
20 participants
Started: Oct 27, 2023 · Completed: Dec 16, 2026
1 condition3 sponsors1 location
NCT06044662
Prognostic Value of Biomarkers in Polyneuropathy.
N/ARecruiting
200 participants
Started: Oct 27, 2023 · Completed: Oct 31, 2026
1 condition1 sponsor1 location
NCT06156956
Fecal Microbiota Transplantation (FMT) to Decolonize Antibiotic - Resistant Bacteria (ARB) - New Protocol
NARecruiting
200 participants
Started: Oct 27, 2023 · Completed: Dec 31, 2025
2 conditions1 sponsor5 locations
NCT05900206
Trastuzumab Deruxtecan Versus Standard Neoadjuvant Treatment for HER2-positive Breast Cancer
PHASE2Recruiting
370 participants
Started: Oct 26, 2023 · Completed: Apr 30, 2032
1 condition1 sponsor7 locations
NCT06155643
EKO SENSORA: Detecting Clinically Significant Murmurs
EARLY_PHASE1Recruiting
300 participants
Started: Oct 26, 2023 · Completed: Jul 26, 2025
1 condition1 sponsor1 location
NCT05892614
Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)
PHASE2Recruiting
25 participants
Started: Oct 26, 2023 · Completed: Apr 30, 2026
1 condition1 sponsor15 locations
NCT06161922
Real World Patient-Reported Outcomes in Chinese Her2+ EBC Patients Receiving (Neo) Adjuvant Anti-Her2 Based Therapy
N/ARecruiting
600 participants
Started: Oct 26, 2023 · Completed: Apr 30, 2025
1 condition1 sponsor1 location
NCT05962450
Adoptive Autologous iNKT Cells for the Treatment of Progressed Hepatocellular Carcinoma Continuing on PD-1 Inhibitor Therapy
PHASE2Recruiting
84 participants
Started: Oct 26, 2023 · Completed: Aug 1, 2025
1 condition2 sponsors1 location
NCT05774652
LiPO Teen (the Lifestyle in Pregnancy and Offspring Teenagers
NARecruiting
301 participants
Started: Oct 26, 2023 · Completed: Apr 1, 2026
5 conditions6 sponsors1 location
NCT06099756
Discharge Readmission Analysis and Management in Sepsis (DReAMS-2)
N/ARecruiting
2,000 participants
Started: Oct 26, 2023 · Completed: Oct 31, 2024
1 condition2 sponsors3 locations
NCT05873686
A Phase 1 Clinical Study of NXP900 in Subjects With Advanced Cancers
PHASE1Recruiting
140 participants
Started: Oct 26, 2023 · Completed: Jul 31, 2027
6 conditions1 sponsor7 locations
NCT06054035
SGLT2 Inhibition in Addition to Lifestyle Intervention and Risk for Complications in Subtypes of Patients With Prediabetes
PHASE4Recruiting
170 participants
Started: Oct 26, 2023 · Completed: Sep 30, 2027
3 conditions4 sponsors9 locations
NCT05923489
Routine Angiography Follow-Up After Percutaneous Coronary Intervention in High-Risk Patients
NARecruiting
2,618 participants
Started: Oct 26, 2023 · Completed: Oct 15, 2029
1 condition9 sponsors1 location
NCT06247605
A Phase IIII Study of AL8326 in Small Cell Lung Cancer
PHASE3Recruiting
243 participants
Started: Oct 26, 2023 · Completed: Jul 31, 2029
1 condition1 sponsor1 location
NCT05655091
Target Attainment of Continuous Infusion Flucloxacillin and Cefazolin Coupled With TDM vs. Standard of Care Treatment in Patients With Complicated S. Aureus Infection
PHASE2Recruiting
36 participants
Started: Oct 26, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT06004856
Evaluate the Efficacy and Safety of Orelabrutinib in Adult Patients With Chronic Primary Immune Thrombocytopenia
PHASE3Recruiting
195 participants
Started: Oct 26, 2023 · Completed: Apr 30, 2026
1 condition1 sponsor45 locations
NCT05725655
Hot Water Immersion After Myocardial Infarction
NARecruiting
30 participants
Started: Oct 26, 2023 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT05792007
Study of the Medullary Microenvironment in Acute Childhood Leukemia
NARecruiting
40 participants
Started: Oct 26, 2023 · Completed: Oct 24, 2028
2 conditions1 sponsor3 locations
NCT05848895
OPT-IN: Osteopathic Plagiocephaly Treatment for Infants and Neonates
NARecruiting
122 participants
Started: Oct 26, 2023 · Completed: Dec 31, 2025
4 conditions1 sponsor1 location
NCT06911697
Study on c-Met Targeted PET/CT Imaging in NSCLC
NARecruiting
88 participants
Started: Oct 26, 2023 · Completed: Jun 28, 2025
2 conditions2 sponsors1 location
NCT05984888
Pilot Study of a MIND Diet Intervention in Women Undergoing Active Treatment for Breast Cancer
NARecruiting
43 participants
Started: Oct 26, 2023 · Completed: Dec 31, 2027
1 condition1 sponsor1 location
NCT05929859
Intensive Speech Motor Chaining Treatment for Residual Speech Sound Disorders
PHASE1/PHASE2Recruiting
84 participants
Started: Oct 26, 2023 · Completed: Feb 29, 2028
1 condition4 sponsors1 location
NCT06066905
A Study of Chidamide With AZA in MRD Positive AML After Transplant
NARecruiting
60 participants
Started: Oct 26, 2023 · Completed: Dec 31, 2026
2 conditions2 sponsors1 location
NCT06103201
Hyperpolarized 13C-pyruvate Metabolic MRI With Traumatic Brain Injury
PHASE1Recruiting
15 participants
Started: Oct 26, 2023 · Completed: Nov 26, 2027
2 conditions1 sponsor1 location
NCT06049212
Sacituzumab Tirumotecan (MK-2870) as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors (MK-2870-008)
PHASE1Recruiting
30 participants
Started: Oct 26, 2023 · Completed: Jan 29, 2027
5 conditions1 sponsor7 locations
NCT06106360
A Pilot Prospective Clinical Trial Using Remote Monitoring for Cancer Patients Undergoing Outpatient Chemotherapy
N/ARecruiting
100 participants
Started: Oct 26, 2023 · Completed: Dec 26, 2025
2 conditions1 sponsor1 location
NCT06182696
OriCAR-017 Chimeric Antigen Receptor (CAR) Modified T Cells for the Treatment of R/RMM
PHASE1/PHASE2Recruiting
83 participants
Started: Oct 26, 2023 · Completed: Aug 31, 2028
1 condition1 sponsor5 locations
NCT06143007
A Phase 1 Study of BB3008 in Participants With Advanced Solid Tumors
PHASE1Recruiting
42 participants
Started: Oct 26, 2023 · Completed: Apr 30, 2026
1 condition1 sponsor2 locations
NCT05935371
Consequences of Obstetric Anal Sphincter Injuries on Maternal Psychology and Relationship Experience
N/ARecruiting
87 participants
Started: Oct 26, 2023 · Completed: Oct 31, 2025
7 conditions2 sponsors1 location
NCT05939999
Effects of Elastic Tape on Pulmonary Rehabilitation of Patients with Chronic Obstructive Pulmonary Disease
NARecruiting
42 participants
Started: Oct 26, 2023 · Completed: May 31, 2025
1 condition1 sponsor1 location
NCT06725758
Two-part, First-in-Human Study on ODM-212 in Subjects with Selected Advanced Solid Tumours
PHASE1/PHASE2Recruiting
315 participants
Started: Oct 26, 2023 · Completed: Dec 31, 2027
1 condition1 sponsor1 location
NCT07007741
Digital Therapy for Fatty Liver Disease
NARecruiting
120 participants
Started: Oct 26, 2023 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT05799040
Evaluation of the Effectiveness of the Self-developed Pulmonary Lobar Ventilation Detector
N/ARecruiting
40 participants
Started: Oct 26, 2023 · Completed: Dec 31, 2024
1 condition1 sponsor1 location